Five thousand miles away in a Pfizer research lab in Groton, Connecticut, infectious disease specialist Scott Hopkins is surfing the Internet when he spots a story on the epidemic--and sees opportunity.
Five of the NYSE's seven specialist firms are believed to be under scrutiny, including market leader LaBranche (nyse: LAB - news - people ), which is in a nasty fight to avoid turning over employee e-mail traffic to investigators.